Application

18282322 · ANTI-ALPP/ALPPL2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

Filed 2023-09-15 · Granted The official file ↗ · Art unit 1643 · Examiner Julie Zhen Qin Wu Typical · CPC A61K 47/68031 · SEAGEN INC. · SEAGEN INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

29.8 mo

to disposition 34.8 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.